SAN RAMON, Calif.—Citing the ongoing impact of COVID-19,
CooperCompanies (NYSE: COO) on Thursday reported that its third-quarter revenue decreased 15 percent year-over-year to $578.2 million, with CooperVision (CVI) revenue falling 12 percent to $449.3 million and CooperSurgical (CSI) revenue dropping 24 percent to $128.9 million.
Read more...